L-Tryptophan · Evidence-First Lite Reference
L-Tryptophan Lite reference · evidence-first overview + FAQ. Educational only.
Overview
This is a Lite reference page for L-Tryptophan. For deep evidence (mechanism, dose-response, full PMID citations), please consult primary literature and the cross-linked references on related goal/lifestyle pages.
Tags
Body Systems: CNS · METABOLISM
Mechanisms: De novo NAD+ via kynurenine pathway · Serotonin precursor · Melatonin precursor
Evidence Tier: lite-tier-c
Layer: B (Lite reference)
Frequently Asked Questions
The questions below cover the most common questions on L-Tryptophan. This is an evidence-first Lite reference page; for deep mechanism narratives, dose-response analyses, and full PMID citations please consult primary literature. Answers below intentionally disclose evidence-base limitations rather than overstate the supplement category.
1. What is L-tryptophan?
L-tryptophan is an essential amino acid. It can contribute to NAD+ production through the kynurenine pathway and is also a biochemical precursor to serotonin and melatonin, but these mechanisms should not be converted into strong mood or sleep outcome claims without endpoint evidence.
2. What is the key evidence anchor for the kynurenine pathway context?
The current evidence review cites Arnone 2018 (PMID 29940237) as the anchor. It is a systematic review and meta-analysis of kynurenine pathway markers in mood-disorder research, finding mixed pathway signals and no simple tryptophan-concentration conclusion. This supports conservative language for /goals/cognitive-support/ rather than a strong mood claim.
3. How does tryptophan relate to NAD+?
Tryptophan can feed de novo NAD+ synthesis through the kynurenine route. The public card uses the classic nutrition conversion frame of 60 mg tryptophan to 1 mg niacin equivalent, while keeping supplement endpoint claims Tier C.
4. What safety boundary matters most?
The clearest practical boundary is interaction risk with serotonergic drugs such as SSRIs or MAOIs, where serotonin syndrome is the concern. The 1989 EMS outbreak is treated as a contamination-linked supplement-history warning rather than proof that pure tryptophan is inherently unsafe.
5. Where does this page sit in the evidence library?
This is a Lite reference page. For deeper evidence please consult primary literature on essential-amino-acid nutrition, kynurenine pathway biochemistry (Arnone 2018 SR anchor), mood and sleep endpoint evidence, and serotonergic drug-interaction safety.